Latest news

Filter by
Date
MEDIA RELEASE: Nov 03, 2012 03:05 PM

When considering bariatric surgery think about bones

Bariatric surgery, which significantly curtails the amount of food a person can eat, is the most effective treatment against obesity and is being recognized as a potentially valuable tool in the fight against diabetes re...

MEDIA RELEASE: Oct 25, 2012 06:00 PM

Unmasking the deadly secrets of pancreatic cancer

A large-scale study that defines the complexity of underlying mutations responsible for pancreatic cancers in more than 100 patients was published in Nature today.

MEDIA RELEASE: Jul 27, 2012 04:20 PM

What pituitary tumours may tell us about the biology of othe...

Garvan scientists in collaboration with Kolling Institute of Medical Research colleagues have published findings that suggest a DNA repair gene called MGMT might have a greater role to play in the growth of cancers than ...

MEDIA RELEASE: Jul 06, 2012 04:00 PM

Understanding how a key group of immune cells is born

A Garvan scientist, in collaboration with colleagues from Switzerland, has demonstrated for the first time how an important class of immune cells, ‘Follicular dendritic cells’, essential for the development of antibodies...

MEDIA RELEASE: Jun 19, 2012 04:20 PM

Improving life for those who suffer most from Type 1 diabete...

A transplant procedure given only to those with Type 1 diabetes who pass out repeatedly from low blood sugar levels, or ‘hypos’, is likely to become much more effective as a result of a discovery made by a group of resea...

MEDIA RELEASE: May 28, 2012 04:20 PM

Taking a muscular approach towards diabetes and other diseas...

Garvan scientists have identified a gene that helps build muscle, a finding that could help unlock therapies for Type 2 diabetes and diseases such as muscular dystrophy, where muscles are weakened or atrophied.

May 16, 2012 04:28 AM

Chairman outlines key Health and Medical Research issues at ...

Chairman of Garvan, Mr Bill Ferris AC, welcomed The Hon Jillian Skinner (Minister for Health and Minister for Medical Research), as well as incoming Executive Director Professor John Mattick, at this year's Annual Genera...

MEDIA RELEASE: Apr 11, 2012 02:05 PM

Potential gene therapy for patients with rare disease

Australian scientists have discovered that a biological phenomenon known as ‘somatic reversion’, when an abnormal gene spontaneously becomes normal again, explains why some patients with a rare genetic disorder live much...

MEDIA RELEASE: Mar 13, 2012 03:05 PM

Creating “death-defying” insulin-producing islets for transp...

Garvan scientists have identified one way of making a frustratingly tricky transplant – of insulin-producing ‘islets of Langerhans’ into patients with Type 1 diabetes – more successful. Part of the Commonwealth-funded Au...

MEDIA RELEASE: Feb 01, 2012 04:05 PM

Understanding why some obese people stay sensitive to insuli...

Obesity, especially central obesity, is associated with insulin resistance, which precedes diabetes, sometimes by more than a decade. However, it’s not only a question of body weight or fat distribution, because some obe...

MEDIA RELEASE: Jan 11, 2012 04:05 PM

Fighting illnesses that accompany the latest anti-psychotic ...

Anti-psychotic drugs for treating serious mental illnesses, such as bipolar disorder or schizophrenia, are effective and often life-saving but come with unwelcome side effects. They dramatically increase weight as well a...

MEDIA RELEASE: Oct 12, 2011 05:20 PM

There is no such thing as identical where twins are concerne...

Identical twins have identical genomes, but that is where it stops. There are subtle differences in their personalities, how they look, how they act and in their susceptibility to disease. How can this be? It depends on ...

MEDIA RELEASE: Sep 22, 2011 02:00 PM

Hope for people with Type 2 diabetes – insulin master switch...

Garvan scientists have discovered that a single gene controls a very complex process, apparently forming the crucial link between eating a high fat diet and developing diabetes. Compounds are already being developed for ...

MEDIA RELEASE: Jun 27, 2011 02:05 PM

Pilot study curbs appetite of people with Prader-Willi Syndr...

Australian researchers have done a promising pilot study on a small group of people with the harrowing genetic disorder known as ‘Prader-Willi Syndrome’, using a drug already prescribed for some patients with Type 2 diab...

MEDIA RELEASE: Jun 05, 2011 05:30 PM

New generation asthma drug could improve metabolism

Formoterol, a new generation asthma medication, shows great promise for improving fat and protein metabolism, say Australian researchers, who have tested this effect in a small sample of men. The researchers present thei...

MEDIA RELEASE: Apr 22, 2011 04:00 PM

Breakthrough study links Type 1 diabetes and Sjögren’s syndr...

Garvan scientists have identified a new group of immune cells that for the first time directly link two autoimmune diseases, Type 1 diabetes and Sjögren’s syndrome. Autoimmune diseases arise when the body’s defences beco...

MEDIA RELEASE: Apr 15, 2011 07:00 PM

Helping pancreatic cancer surgeons make tiebreaker decisions...

Garvan researchers have identified two ‘biomarkers’ that appear to have the ability to predict patient survival after surgery for pancreatic cancer before the operation takes place. It is the first predictive tool of its...

MEDIA RELEASE: Apr 04, 2011 02:00 AM

Test Vitamin D levels in pregnant women say researchers

Australian clinical researchers have identified widespread Vitamin D deficiency in pregnant women as well as a very strong association between low Vitamin D levels and gestational diabetes.

MEDIA RELEASE: Feb 12, 2011 05:00 AM

How nasal stem cells might prevent childhood deafness

Researchers at Garvan have shown for the first time in mice that nasal stem cells injected into the inner ear have the potential to reverse or restore hearing during early onset sensorineural hearing loss.

MEDIA RELEASE: Feb 03, 2011 05:00 PM

An extra 5 years of life an unexpected benefit of osteoporos...

Clinical researchers at Garvan have noted an extraordinary and unexpected benefit of osteoporosis treatment – that people taking bisphosphonates are not only surviving well, better than people without osteoporosis, they ...

MEDIA RELEASE: Jan 17, 2011 06:20 PM

Improved rationale for attacking colorectal cancer

Some people respond very well to chemotherapy or radiotherapy for colorectal cancer, while others hardly respond at all – a fact that has been a bit of a mystery until now. A team of Garvan scientists believes the outcom...